RNA Modification by m(6)A Methylation in Cardiovascular Disease.
RNA Modification by m(6)A Methylation in Cardiovascular Disease.
复制标题
DOI:
10.1155/2021/8813909
复制
发表时间:
2021
影响因子:
--
通讯作者:
Jiang DS
中科院分区:
文献类型:
--
作者:
Chen J;Wei X;Yi X;Jiang DS
Cardiovascular disease is currently the leading cause of death worldwide, and its underlying regulatory mechanisms remain largely unknown. N6-Methyladenosine (m6A) RNA methylation is an epigenetic modification involved in the splicing, nuclear export, translational regulation, and degradation of RNA. After the initial identification of m6A RNA methylation in 1974, the rise of next-generation sequencing technology to detect m6A throughout the transcriptome led to its renewed recognition in 2012. Since that time, m6A methylation has been extensively studied, and its functions, mechanisms, and effectors (e.g., METTL3, FTO, METTL14, WTAP, ALKBH5, and YTHDFs) in various diseases, including cardiovascular diseases, have rapidly been investigated. In this review, we first examine and summarize the molecular and cellular functions of m6A methylation and its readers, writers, and erasers in the cardiovascular system. Finally, we discuss future directions for m6A methylation research and the potential for therapeutic targeting of m6A modification in cardiovascular disease.
登录
查看更多内容
影响因子:
3.6
作者:
Davis, Wiliam;van Rensburg, Susan J.;Kotze, Maritha J.
通讯作者:
Kotze, Maritha J.
影响因子:
9.2
作者:
Chen, Tai-Qiang;Hu, Nan;Jiang, Ding-Sheng
通讯作者:
Jiang, Ding-Sheng
影响因子:
56.9
作者:
Frayling, Timothy M.;Timpson, Nicholas J.;McCarthy, Mark I.
通讯作者:
McCarthy, Mark I.
影响因子:
--
作者:
Gustavsson, Jaana;Mehlig, Kirsten;Nyberg, Fredrik
通讯作者:
Nyberg, Fredrik
影响因子:
18.2
作者:
Berulava, Tea;Buchholz, Eric;Toischer, Karl
通讯作者:
Toischer, Karl